Then, we determined their cellular origin (melanoma cells or immune cells, as T and B lymphocytes, monocytes and dendritic cells) by measuring the percentage of EVs positive for CD146, CD8, CD19, CD14 and CD1a, respectively (Fig. 1C). This evidence concerns the gene CD19 and melanoma.